Cancer Biology & Therapy
Overview
Cancer Biology & Therapy is a peer-reviewed journal that focuses on the latest advancements in cancer research and therapy. It covers a wide range of topics, including molecular biology, tumor immunology, targeted therapies, and clinical trials. With its interdisciplinary approach, the journal provides valuable insights into the understanding and treatment of cancer, making it an essential resource for researchers, clinicians, and students in the field.
Details
Details
Abbr.
Cancer Biol Ther
Start
2002
End
Continuing
Frequency
Semimonthly, 2009-
p-ISSN
1538-4047
e-ISSN
1555-8576
Country
United States
Language
English
Specialties
Oncology
Pharmacology
Pharmacology
Metrics
Metrics
h-index / Ranks: 1919
130
SJR / Ranks: 4389
914
CiteScore / Ranks: 1502
9.80
JIF / Ranks: 2654
3.6
Recent Articles
1.
Fines C, McCarthy H, Buckley N
Cancer Biol Ther
. 2025 Mar;
26(1):2472432.
PMID: 40089851
Nearly 20 million people are diagnosed with cancer each year with breast cancer being the most common among women. Triple negative breast cancer (TNBC), defined by its no/low expression of...
2.
Chang T, Fang W, Hsu H, Chu P, Jiang S, Huang K, et al.
Cancer Biol Ther
. 2025 Mar;
26(1):2478670.
PMID: 40081967
, which encodes mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M), is upregulated in various cancers. We demonstrated high expression of PEPCK-M in approximately half of triple-negative breast cancers (TNBCs) previously. TNBC is associated...
3.
Noreen S, Ishaq I, Saleem M, Ali B, Ali S, Iqbal J
Cancer Biol Ther
. 2025 Mar;
26(1):2475581.
PMID: 40079211
Early and precise diagnosis of cancer is pivotal for effective therapeutic intervention. Traditional diagnostic methods, despite their reliability, often face limitations such as invasiveness, high costs, labor-intensive procedures, extended processing...
4.
Zhong L, Zhu J, Chen J, Jin X, Liu L, Ji S, et al.
Cancer Biol Ther
. 2025 Mar;
26(1):2475604.
PMID: 40069131
Breast cancer remains a global health challenge with varied prognoses despite treatment advancements. Therefore, this study explores the pseudogene MGAT4EP as a potential biomarker and therapeutic target in breast cancer....
5.
Tian R, Song H, Li J, Yuan T, Liu J, Wang Y, et al.
Cancer Biol Ther
. 2025 Mar;
26(1):2477365.
PMID: 40065703
Purpose: Abnormal expression of PINCH-1 has been observed in various types of human cancers. However, the clinical importance and mechanism underlying its role in head and neck squamous cell carcinoma...
6.
Luo Y, Zhong X, Sun X, Fan J
Cancer Biol Ther
. 2025 Feb;
26(1):2469927.
PMID: 40018990
Our study aims to investigate the roles of embryonic lethal abnormal vision-like 1 (ELAVL1) and long non-coding RNA (LncRNA) NEAT1 in endometrial cancer (EC), focusing on their underlying molecular mechanisms.We...
7.
Jung C, Kim J, Park M
Cancer Biol Ther
. 2025 Feb;
26(1):2471631.
PMID: 39992057
CXC Chemokine receptor type 4 (CXCR4) is commonly considered a potential marker for cancer stem cells (CSCs). Dedifferentiated-type chordoma (DTC) cells derived from a patient with recurrent chordoma exhibit high...
8.
Fang F, Zhao M, Meng J, He J, Yang C, Wang C, et al.
Cancer Biol Ther
. 2025 Feb;
26(1):2464966.
PMID: 39930621
Metastasis is the predominant culprit of cancer-associated mortality in non-small cell lung cancer (NSCLC). Tweety homolog 3 (TTYH3) reportedly functions vitally in the development of diverse cancers, including NSCLC; nevertheless,...
9.
Al-Hamaly M, Winter E, Blackburn J
Cancer Biol Ther
. 2025 Feb;
26(1):2460252.
PMID: 39905687
Acute lymphocytic leukemia (ALL) is the most common leukemia in children, with the T-cell subtype (T-ALL) accounting for 15% of those cases. Despite advancements in the treatment of T-ALL, patients...
10.
Quan Z, Fan S, Zheng H, Ning Y, Yang Y
Cancer Biol Ther
. 2025 Jan;
26(1):2458773.
PMID: 39881438
Membrane-associated RING-CH8 (MARCH8) is a member of the recently discovered MARCH family of ubiquitin ligases. MARCH8 has been shown to participate in immune responses. However, the role of MARCH8 in...